Common adverse effects of Ozempic, as documented in the UK SmPC, include: Gastrointestinal symptoms : nausea, vomiting, diarrhoea, constipation, abdominal pain (very common, affecting more than 1 in 10 patients) Decreased appetite (very common) Hypoglycaemia : when used in combination with insulin or sulphonylureas Gallbladder disorders : including cholelithiasis and cholecystitis Fatigue Injection site reactions : such as bruising or pain Whilst musculoskeletal pain is not formally listed, healthcare professionals should remain vigilant for patient reports and consider the broader context of treatment, including weight loss trajectory, nutritional status, and concurrent medical conditions
Less physical strain, leading to reduced joint pain and improved mobility
Early recognition and appropriate evaluation are key to addressing the root cause and improving quality of life
Patients should discuss with their doctor any potential disadvantages, such as the risk of hypoglycemia, particularly if taking other blood glucose-lowering medications
They are trying to understand why some people who take Semaglutide experience GERD symptoms, while others do not